Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer
Jinani Jayasekera(National Institutes of Health), E. Shelley Hwang(Duke Medical Center), Richard C. Zellars(The University of Texas at San Antonio Health Science Center), Timothy J. Whelan(Juravinski Cancer Centre), Stewart Anderson(Zimmer Biomet (Netherlands)), Jeanne S. Mandelblatt(Georgetown University), Julia White(The Ohio State University Wexner Medical Center), George Luta(Georgetown University), Judith O. Hopkins(Novant Health), Juhee Song(The University of Texas MD Anderson Cancer Center), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Eric J. Feuer(National Cancer Institute), Clyde B. Schechter(Albert Einstein College of Medicine), Donald A. Berry(Berry & Associates (United States)), Reshma Jagsi(Emory University), Robert J. Gray(University of Glasgow), Anthony Fyles(University Health Network), Thomas B. Julian(Allegheny Health Network), Joseph A. Sparano(Tisch Cancer Institute), Yisheng Li(The University of Texas MD Anderson Cancer Center), Natasha K. Stout(Harvard Pilgrim Health Care), Joseph P. Costantino(NSABP Foundation), Willi Sauerbrei(University Medical Center Freiburg), Judith‐Anne W. Chapman(Queen's University)
Cited by 21
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
|New England Journal of Medicine|2020|1.7k
An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis.
|PubMed|2013|1.6k
Regional Nodal Irradiation in Early-Stage Breast Cancer
|New England Journal of Medicine|2015|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k